Xadago is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Us Worldmeds, Llc. The primary component is Safinamide Mesylate.
| Product ID | 27505-110_0e434cb6-5220-44c2-a9cc-0b085946a007 |
| NDC | 27505-110 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Xadago |
| Generic Name | Safinamide Mesylate |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-05-08 |
| Marketing Category | NDA / NDA |
| Application Number | NDA207145 |
| Labeler Name | US WorldMeds, LLC |
| Substance Name | SAFINAMIDE MESYLATE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2017-05-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA207145 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-05-08 |
| Marketing Category | NDA |
| Application Number | NDA207145 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-05-08 |
| Marketing Category | NDA |
| Application Number | NDA207145 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-05-08 |
| Ingredient | Strength |
|---|---|
| SAFINAMIDE MESYLATE | 50 mg/1 |
| SPL SET ID: | c4d65f28-983f-42b4-bb23-023ae0fe81b2 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 27505-110 | Xadago | safinamide mesylate |
| 27505-111 | Xadago | safinamide mesylate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() XADAGO 85842346 4630663 Live/Registered |
ZAMBON S.P.A. 2013-02-06 |